Sequana Medical NV (SEQUA) | Stock Overview & Key Data

Sequana Medical NV | Small-cap | Healthcare

€1.03

2.99%

| Sequana Medical NV Stock Comparison:

Sequana Medical NV vs Ion Beam Sequana Medical NV vs Argenx SE Sequana Medical NV vs Solvac S.A Sequana Medical NV vs Fagron NV Sequana Medical NV vs Nyxoah S.A Sequana Medical NV vs BEL 20 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Sequana Medical NV Performance Comparison

Loading chart data...

Sequana Medical NV

BEL 20

View Full Price History

Stock Range

Today's Range

Low: €1.00 High: €1.05

on June 17, 2025

52 Week Range

Low: €0.47 High: €4.39

on October 1, 2024

on December 27, 2024

All-Time High: €12.40 on January 4, 2021

Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights

Key Statistics

Market Cap i €57.4M

EPS i -0.91

P/E Ratio (TTM) i -0.82

Forward P/E i -0.84

P/B Ratio i N/A

PEG Ratio i -0.84

Div. Yield i 0.00%

ROE i 167.29%

Beta i -0.072

Debt to Equity i -2.06

Financial Highlights

Profitability

Gross Margin i 84.98%

Operating Margin i -17,731.38%

Profit Margin i 76.95%

Returns and Earnings

Return on Assets (TTM) i -116.66%

Return on Equity (TTM) i 167.29%

EBITDA i €-18.4M

Net Income (TTM) i €-44.7M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Sequana Medical NV SEQUA	57.44M Small-cap	7.29%	1.98%	-35.22%	41.10%	-57.96%	-32.43%	-80.31%	-84.57%
Ion Beam IBAB	363.48M Mid-cap	-3.69%	5.45%	-6.25%	-8.95%	-12.02%	-8.53%	-17.43%	55.67%
Argenx SE ARGX	30.72B Large-cap	-5.90%	-4.22%	-13.76%	-20.25%	-20.91%	39.26%	51.84%	157.48%
Solvac S.A SOLV	1.87B Large-cap	0.00%	1.14%	-7.87%	-13.17%	-10.28%	-20.55%	-7.02%	-8.19%
Fagron NV FAGR	1.60B Large-cap	-0.23%	2.58%	13.92%	18.88%	30.37%	23.59%	35.27%	12.31%
Nyxoah S.A NYXH	252.65M Mid-cap	-2.87%	18.56%	-30.21%	-12.76%	-21.28%	-7.79%	-36.92%	-65.38%

Ownership & Short Interest

Insider Ownership i 22.22%

Institutional Ownership i 47.05%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 293K

Average 90-Day Volume i 340K

Sequana Medical NV Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Sequana Medical NV would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is SEQUA's 52-week high and low?

In the last 52 weeks, Sequana Medical NV reached a high of €4.39 (on December 27, 2024) and a low of €0.47 (on October 1, 2024).

What is the market cap and P/E ratio for SEQUA?

Curious about Sequana Medical NV's size and valuation? Its market capitalization stands at 57.44M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.82, and the forward P/E (looking ahead) is -0.84.

Does SEQUA pay dividends? If so, what's the yield?

As for dividends, Sequana Medical NV isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Sequana Medical NV's main competitors or similar companies to consider before investing?

When looking at Sequana Medical NV, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Ion Beam IBAB	363.48M	Healthcare	Medical Devices	-8.53%	-17.43%
Argenx SE ARGX	30.72B	Healthcare	Biotechnology	39.26%	51.84%
Solvac S.A SOLV	1.87B	Healthcare	Medical Instruments & Supplies	-20.55%	-7.02%
Fagron NV FAGR	1.60B	Healthcare	Drug Manufacturers - Specialty & Generic	23.59%	35.27%
Nyxoah S.A NYXH	252.65M	Healthcare	Medical Instruments & Supplies	-7.79%	-36.92%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Sequana Medical NV? (e.g., ROE, Debt/Equity)

To get a sense of Sequana Medical NV's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 167.29%, the Debt to Equity ratio from the most recent quarter is -2.06, and its Gross Profit Margin stands at 84.98%.

What is the recent revenue and earnings growth for SEQUA?

Looking at Sequana Medical NV's growth, its revenue over the trailing twelve months (TTM) was €106K. Compared to the same quarter last year (YoY), quarterly revenue grew by -100.00%, and quarterly earnings saw a YoY growth of N/A.

How much of SEQUA stock is held by insiders and institutions?

Wondering who owns Sequana Medical NV stock? Company insiders (like executives and directors) hold about 22.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 47.05%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.